Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-28

Clinical Trial Update: PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial update on PSMA-PET guided hypofractionated salvage radiotherapy to the prostate bed for recurrent prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Medical Center Groningen | Conditions: Prostate Cancer, Cancer Recurrence | Phase 3 | Status: RECRUITING